HOME >> BIOLOGY >> NEWS
New test proves effective in more cancers

Sydney, Australia; San Diego, CA, USA - October 6, 2005 - Avantogen Limited (ACU:ASX) today announced that cancer researchers at Perth's Telethon Institute for Child Health Research (TICHR) and Avantogen Limited have achieved an important milestone towards more individually targeted and effective treatments for cancer patients.

The research team has now identified crucial genes in a range of common cancers that have been reported to predict a patient's response to treatment. This follows the team's earlier success in studying a tumor suppressor gene associated with acute lymphoblastic leukaemia (ALL) in children.

By using a simple test developed at the Institute, they can rapidly detect the presence or absence of these tumor suppressor genes in the patient's cancer cells. Tumor suppressor genes are linked to a variety of cancers including lung, breast, renal, colorectal, pancreatic, gastric, lymphoma and malignant melanoma.

Professor Ursula Kees, who heads the Children's Leukaemia and Cancer Research Division at TICHR, said progress over the past 18 months has been excellent.

"The absence of specific tumor suppressor genes in tumor specimens provides a valuable genetic marker to help us determine who is at greater risk of relapse," she said.

"We've now used this new rapid test in a cancer that occurs in adults and found it to be effective in providing important information about the genetic makeup of the tumor - information that doctors could use at an early stage to decide on the most effective treatment regimen for that individual patient."

Dr Leonard Firestone, CEO and managing director of Avantogen, said his company is currently considering the most appropriate commercial model to bring the test to the market. The new test is based on fast and simple procedures that can be run out of most diagnostic laboratories.

Director of the Telethon Institute for Child Health Research, Professor Fiona Stanley, said
'"/>

Contact: Tammy Gibbs
61-894-897-963
Research Australia
6-Oct-2005


Page: 1 2

Related biology news :

1. New test improves detection of liver cancer
2. New research proves single origin of humans in Africa
3. Jefferson scientists patent dramatically improves
4. Co-operation between GSF and clinic improves outlook for sarcoma patients
5. High blood pressure medication strategy proves effective in Hispanic women
6. An elegant idea proves its worth 25 years later
7. HIV survival improves if patients stay in care
8. Preterm infants with RDS -- surfactant replacement therapies improves neonatal survival
9. New knowledge improves rice quality
10. Statin treatment improves spatial memory in mouse models of Alzheimers
11. Mutation improves memory, may lead to memory-enhancing pill

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... to 2025" report to their offering. ... The Global Biometric Vehicle Access System Market ... the next decade to reach approximately $1,580 million by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):
(Date:7/27/2017)... ... July 27, 2017 , ... ... businesses to participate in Lajollacooks4u’s popular corporate team building events this summer. ... in Lajollacooks4u’s signature olive oil competition to whet their palettes. Three teams ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... worldwide rights to SQuEEZ heart function analysis software, and an associated pending patent ... was filed April 10, 2014 and uses high resolution cardiac CT to analyze ...
(Date:7/26/2017)... Biosciences Inc., a world leading specialty CRO announced the publication ... early stage (latent) Mycobacterium tuberculosis (Mtb) infection using state-of-the-art ProteoCarta™, ... ... Caprion Biosciences Inc. (CNW Group/Caprion Biosciences) ... The new data, recently published in EbioMedicine ...
(Date:7/26/2017)... Ca (PRWEB) , ... July 25, 2017 , ... ... August 22, attendees will garner a better understanding of the considerations needed for ... CRISPR-Cas9 applications. , The use of CRISPR-Cas9 to create targeted double-strand breaks in ...
Breaking Biology Technology:
Cached News: